UBS Group’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.2M | Buy |
|
|||||
|
2025
Q1 | $45.7M | Buy |
|
|||||
|
2024
Q4 | $38.9M | Buy |
|
|||||
|
2024
Q3 | $2.05M | Sell |
|
|||||
|
2024
Q2 | $2.88M | Sell |
|
|||||
|
2024
Q1 | $4.86M | Buy |
|
|||||
|
2023
Q4 | $6.78K | Sell |
|
|||||
|
2023
Q3 | $341K | Sell |
|
|||||
|
2023
Q2 | $1.33M | Buy |
|
|||||
|
2023
Q1 | $977K | Sell |
|
|||||
|
2022
Q4 | $2.86M | Buy |
|
|||||
|
2022
Q3 | $450K | Buy |
|
|||||
|
2022
Q2 | $357K | Sell |
|
|||||
|
2022
Q1 | $1.05M | Sell |
|
|||||
|
2021
Q4 | $1.13M | Buy |
|
|||||
|
2021
Q3 | $720K | Buy |
|
|||||
|
2021
Q2 | $309K | Sell |
|
|||||
|
2021
Q1 | $591K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $18K | Sell |
|
|||||
|
2020
Q2 | $94K | Sell |
|
|||||
|
2020
Q1 | $193K | Buy |
|